News and Media Filter All News Article Press Release Webcast Page: 1 of 4 September 5, 2023 Press Release Remix Therapeutics to Participate in Upcoming Investor Conferences May 25, 2023 Press Release Remix Therapeutics to Present at Jefferies Healthcare Conference March 22, 2023 Press Release Remix Therapeutics Appoints Robert Gagnon as Chief Financial Officer December 8, 2022 Press Release Remix Therapeutics to Present at 5th Annual RNA-Targeted Drug Discovery Summit January 5, 2023 Press Release Remix Therapeutics Appoints Christopher Bowden, M.D., as Chief Medical Officer Media Contact Lissette Steele Verge Scientific Communications 202.930.4762 lsteele@vergescientific.com Media Contact Lissette Steele Verge Scientific Communications 202.930.4762 lsteele@vergescientific.com
